PMDA drug package insert
コンドロイチンZS錠
PMDA OTC drug · ゼリア新薬工業（株） · package insert Oct 15, 2015
Key facts
| Brand names | コンドロイチンZS錠 |
|---|---|
| Companies | 製造販売元／ゼリア新薬工業（株） |
| Product type | OTC drug |
| OTC risk class | 第３類医薬品 |
| OTC dosage form | 錠剤 |
| OTC effect category | その他の精神神経用薬 |
| Package insert date | Oct 15, 2015 |
| PMDA document key | 380077_J0601001854 |
| PMDA company code | 380077 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: